HOYA - YOUR PARTNER IN CELL THERAPY
Helping our clients turn science into medicines with sound business profiles, while making a meaningful impact on patients’ lives.
Driving the promise of hPSC derived medicines
Bring cell therapy aspirations to ‘the bedside’ and to commercialisation for patients in need. Harness our network and know-how in hPSC-based cell therapy manufacturing and venture creation.
hPSC-ATMP manufacture - Where are we now?
Read the first in our series of white papers as a follow-up to the 'Tillväxtverket pilot study for hPSC derived cell therapies Innovation catalyst'.
Unlock the World of HOYA Member’s Portal
Are you ready to delve into the exclusive world of HOYA Membership? Elevate your knowledge and expand your network in the field of induced pluripotent stem cells (iPSC). Our member portal is a gateway to invaluable resources, insights, and connections.
To explore the benefits of HOYA Membership and start your journey towards excellence, simply click below and find out more.
Press here to read more
〰️
Press here to read more 〰️
Clients and collaborators
Projects completed
HOYA partnering with CDMOs and TTOs for Cell Therapy Success
Whether you are a CDMO looking to expand your capabilities or a TTO seeking to commercialize innovative technologies, HOYA Consulting is your trusted partner for success in the evolving field of cell therapy. Contact us today to explore how we can collaborate to achieve your goals and accelerate the development of life-changing therapies.
TEAM
-
ANNA FALK, Prof.
hiPSC researcher and Principal Investigator
Based in Lund & Stockholm, SE. -
HEATHER MAIN, PhD
hPSC-ATMP developer, Communication and Project Management
Based in Melbourne, AU. -
AJDIN JAKUPOVIC, Dual M.Sc.
Project Management, Business Development, Market Analysis
Based in Stockholm, SE.

What our clients say
